A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis

PLoS Neglected Tropical Diseases

Volumn 2, Issue 10, 2008, Pages

  Limmathurotsakul, Direk ^a   Chaowagul, Wipada ^b   Chantratita, Narisara ^a   Wuthiekanun, Vanaporn ^a   Biaklang, Mayurachat ^a   Tumapa, Sarinna ^a   White, Nicholas J ^a,b   Day, Nicholas P J ^a,b   Peacock, Sharon J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; MEROPENEM; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BOOTSTRAPPING; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; INTERNAL VALIDITY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RECURRENT INFECTION; REINFECTION; RELAPSE; SCORING SYSTEM; SEASONAL VARIATION; THAILAND; TREATMENT DURATION; BURKHOLDERIA PSEUDOMALLEI; DIAGNOSTIC PROCEDURE; DRUG EFFECT; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE;

ADULT; ANTI-BACTERIAL AGENTS; BURKHOLDERIA PSEUDOMALLEI; DIAGNOSTIC TECHNIQUES AND PROCEDURES; FEMALE; HUMANS; MALE; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; RECURRENCE; THAILAND; YOUNG ADULT;

EID: 56149098131     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000327     Document Type: Article

References (40)

1. White NJ (2003) Melioidosis. Lancet 361: 1715-1722.
2. Suputtamongkol Y, Hall AJ, Dance DA, Chaowagul W, Rajchanuvong A, et al. (1994) The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol 23: 1082-1090.
3. Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, et al. (2000) The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 74: 121-127.
4. Currie BJ, Fisher DA, Howard DM, Borrow JN, Lo D, et al. (2000) Endemic melioidosis in tropical northern Australia: A 10-year prospective study and review of the literature. Clin Infect Dis 31: 981-986.
5. Chaowagul W, Suputtamongkol Y, Dance DA, Rajchanuvong A, Pattaraarechachai J, et al. (1993) Relapse in melioidosis: Incidence and risk factors. J Infect Dis 168: 1181-1185.
6. Maharjan B, Chantratita N, Vesaratchavest M, Cheng A, Wuthiekanun V, et al. (2005) Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol 43: 6032-6034.
7. Limmathurotsakul D, Chaowagul W, Chierakul W, Stepniewska K, Maharjan B, et al. (2006) Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 43: 979-986.
8. Walsh AL, Wuthiekanun V (1996) The laboratory diagnosis of melioidosis. Br J Biomed Sci 53: 249-253.
9. Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, et al. (2003) Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol 41: 2068-2079.
10. Wuthiekanun V, Cheng AC, Chierakul W, Amornchai P, Limmathurotsakul D, et al. (2005) Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother 55: 1029-1031.
11. Clinical and Laboratory Standards Institute (CLSI) (2008) Performance Standards for Antimicrobial Susceptiblity Testing. Wayne, PA.
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (1997) Diabetes Care 20: 1183-1197.
13. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. (2002) Am J Kidney Dis 39: S1-266.
14. Singri N, Ahya SN, Levin ML (2003) Acute renal failure. JAMA 289: 747-751.
15. Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley-Interscience Publication.
16. Caminero JA (2005) Management of multidrug-resistant tuberculosis and patients in retreatment. Eur Respir J 25: 928-936.
17. Lee YL, Lee SS, Tsai HC, Chen YS, Wann SR, et al. (2006) Pyogenic liver abscess caused by Burkholderia pseudomallei in Taiwan. J Formos Med Assoc 105: 689-693.
18. Chadwick DR, Ang B, Sitoh YY, Lee CC (2902) Cerebral melioidosis in Singapore: A review of five cases. Trans R Soc Trop Med Hyg 96: 72-76.
19. Chiang CY, Riley LW (2005) Exogenous reinfection in tuberculosis. Lancet Infect Dis 5: 629-636.
20. Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, et al. (2003) Recurrence in tuberculosis: Relapse or reinfection? Lancet Infect Dis 3: 282-287.
21. Ohrt C, Mirabelli-Primdahl L, Karnasuta C, Chantakulkij S, Kain KC (1997) Distinguishing Plasmodium falciparum treatment failures from reinfections by restrictions fragment length polymorphism and polymerase chain reaction genotyping. Am J Trop Med Hyg 57: 430-437.
22. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, et al. (2007) Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis 195: 927-933.
23. Fowler VG Jr, Kong LK, Corey GR, Gottlieb GS, McClelland RS, et al. (1999) Recurrent Staphylococcus aureus bacteremia: Pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 179: 1157-1161.
24. Font B, Lliminana C, Fontanals D, Pineda V, Segura F (2001) Eleven-year study of recurrent pneumococcal bacteremia. Eur J Clin Microbiol Infect Dis 20: 636-638.
25. Chu VH, Sexton DJ, Cabell CH, Reller LB, Pappas PA, et al. (2005) Repeat infective endocarditis: Differentiating relapse from reinfection. Clin Infect Dis 41: 406-409.
26. Tang-Feldman Y, Mayo S, Silva JJ Jr, Cohen SH (2003) Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol 41: 3413-3414.
27. Rello J, Mariscal D, March F, Jubert P, Sanchez F, et al. (1998) Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med 157: 912-916.
28. Werner G, Klare I, Witte W (2007) The current MLVA typing scheme for Enterococcus faecium is less discriminatory than MLST and PFGE for epidemic-virulent, hospital-adapted clonal types. BMC Microbiol 7: 28.
29. Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, et al. (2008) Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: Restriction endonuclease analysis pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 46: 431-437.
30. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38: 1008-1015.
31. Nadelman RB, Wormser GP (2007) Reinfection in patients with Lyme disease. Clin Infect Dis 45: 1032-1038.
32. Cheng AC, Jacups SP, Anstey NM, Carrie BJ (2003) A proposed scoring system for predicting mortality in melioidosis. Trans R Soc Trop Med Hyg 97: 577-581.
33. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, et al. (2004) A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291: 1720-1729.
34. Pitt TL, Trakulsomboon S, Dance DA (2007) Recurrent melioidosis: possible role of infection with multiple strains of Burkholderia pseudomallei. J Clin Microbiol 45: 680-681.
35. Limmathurotsakul D, Wuthiekanun V, Chantratita N, Wongsuvan G, Thanwisai A, et al. (2007) Simultaneous infection with more than one strain of Burkholderia pseudomallei is uncommon in human melioidosis. J Clin Microbiol.
36. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95: 3140-3145.
37. Chantratita N, Wuthiekanun V, Limmathurotsakul D, Vesaratchavest M, Thanwisai A, et al. (2008) Genetic Diversity and Microevolution of Burkholderia pseudomallei in the Environment. PLoS Negl Trop Dis 2: E182 doi:10.1371/journal.pntd.0000182.
38. Dance DA, Wuthiekanun V, Chaowagul W, White NJ (1989) The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 24: 295-309.
39. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD (2004) Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 54: 1134-1138.
40. Dance DA, Wuthiekanun V, Chaowagul W, Suputtamongkol Y, White NJ (1991) Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei. J Antimicrob Chemother 28: 321-324.